Clinical Trial News and Research

RSS

Ashwagandha boosts memory and mood in clinical trial

A clinical trial found that acute and 30-day Ashwagandha supplementation improves cognitive function and mood markers, showing significant benefits in memory, attention, and well-being without adverse effects.

10 Jun 2024

Can lifestyles changes reduce Alzheimer’s risk?

Intensive lifestyle changes significantly improve cognition and function in patients with mild cognitive impairment or early dementia due to Alzheimer’s disease over a 20-week period, showing promising results for non-pharmacological interventions.

10 Jun 2024

Precision-guided treatment boosts outcomes in children with high-risk cancers

Study reveals that precision-guided treatment (PGT) improves outcomes in high-risk pediatric cancer patients, but clinical adoption remains low due to physician uncertainty and lack of long-term survival data.

10 Jun 2024

Stanford study finds 15-day paxlovid treatment safe but ineffective for long COVID

In a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid -; an antiviral drug combination targeting SARS-CoV-2, the virus that causes COVID-19 -; proved safe as an extended-duration treatment but didn't lessen select symptoms of the syndrome known as long COVID: the persistence, or reappearance, of COVID-related symptoms three months or more after an initial COVID-19 infection.

7 Jun 2024

New biological mechanism uncovered for treating breast cancer metastasis to the brain

A study led by researchers from the University of Arizona Cancer Center at UArizona Health Sciences identified a biological mechanism that could lead to more effective treatments for breast cancer that has metastasized to the brain.

7 Jun 2024

Study finds service dogs reduce PTSD, anxiety, and depression in veterans

The associations between psychiatric service dog partnership and post-traumatic stress disorder (PTSD) among veterans.

7 Jun 2024

New 5-minute cognitive test boosts dementia care in diverse elderly populations

The 5-Cog tool significantly enhances dementia diagnosis and care for older adults in primary care, especially among Black and Hispanic communities, by being culturally sensitive and quick to administer.

6 Jun 2024

New hope for BCG-unresponsive bladder cancer patients with innovative combination therapy

In a groundbreaking advance that could revolutionize bladder cancer treatment, a novel combination of cretostimogene grenadenorepvec and pembrolizumab has shown remarkable efficacy in patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer.

6 Jun 2024

Precision medicine revolutionizes outcomes for high-risk pediatric cancer patients

In a world-first, Australian researchers and clinicians have shown that precision medicine – where treatment is tailored to an individual child's cancer – leads to significantly improved outcomes in children with high risk cancer.

6 Jun 2024

Low-dose direct oral anticoagulants linked to increased bleeding risk in Afib patients

Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more bleeding episodes during the first three months of treatment and about one in five had high blood levels of the medications, compared with similar patients who took standard doses of the same medications, according to a study published in Blood Advances.

6 Jun 2024

Researchers investigate the feasibility of new home-administered treatment for binge eating disorder

Researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London have investigated the feasibility of a new home-administered treatment for binge eating disorder.

6 Jun 2024

Ultrasound technology breaks blood-brain barrier for glioblastoma treatment

In a major advance for the treatment of the deadly brain cancer glioblastoma, Northwestern Medicine scientists used ultrasound technology to penetrate the blood-brain barrier and provide a small dose of a chemotherapy and immunotherapy drug cocktail.

6 Jun 2024

How a low-nicotine cigarette policy could improve public health

A recent study in The Lancet Regional Health shows low-nicotine cigarettes significantly reduce daily cigarette use and increase smoke-free days, even when alternative nicotine delivery systems are available.

5 Jun 2024

Short course of immunotherapy prior to surgery effective in treating a subset of colon cancer patients

A short course of immunotherapy was found to be highly effective in a subset of patients with colon cancer.

5 Jun 2024

$Preoperative antibiotic treatment does not reduce infection risk after pediatric elbow fracture surgery$

Preoperative antibiotic treatment does not reduce infection risk after pediatric elbow fracture surgery

Antibiotic treatment prior to surgical repair of a pediatric elbow fracture does not reduce the risk for post-operative infection, according to new findings from a team of researchers and surgeons from the University of Missouri School of Medicine.

5 Jun 2024

New bilateral gene therapy shows promising results in treating genetic hearing loss

A novel gene therapy designed to target a form of inherited deafness restored hearing function in five children who were treated in both ears.

5 Jun 2024

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

UC San Diego Health is the first hospital system in the region to offer a new immunotherapy treatment for metastatic melanoma.

4 Jun 2024

5-Cog paradigm: A breakthrough in dementia diagnosis and care

The underdiagnosis of dementia, especially among Black and Hispanic patients, is a long-standing challenge in medicine.

4 Jun 2024

New program aims to reduce the strain on caregivers of children with ADHD

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by elevated levels of inattention, impulsivity, and hyperactivity that can impair academic and social functioning.

4 Jun 2024

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

The combination of the antibody amivantamab and lazertinib, a drug targeting EGFR, shows better clinical benefits compared to standard treatment in patients with advanced or metastatic non-small cell lung cancer with EGFR gene mutations who also present one of these poor prognosti markers: brain and/or liver metastases, p53 gene co-mutations, or the presence of circulating tumor DNA.

4 Jun 2024

1
2
3
4
...
1061
Next

Clinical Trial News and Research

Ashwagandha boosts memory and mood in clinical trial

Can lifestyles changes reduce Alzheimer’s risk?

Precision-guided treatment boosts outcomes in children with high-risk cancers

Stanford study finds 15-day paxlovid treatment safe but ineffective for long COVID

New biological mechanism uncovered for treating breast cancer metastasis to the brain

Study finds service dogs reduce PTSD, anxiety, and depression in veterans

New 5-minute cognitive test boosts dementia care in diverse elderly populations

New hope for BCG-unresponsive bladder cancer patients with innovative combination therapy

Precision medicine revolutionizes outcomes for high-risk pediatric cancer patients

Low-dose direct oral anticoagulants linked to increased bleeding risk in Afib patients

Researchers investigate the feasibility of new home-administered treatment for binge eating disorder

Ultrasound technology breaks blood-brain barrier for glioblastoma treatment

How a low-nicotine cigarette policy could improve public health

Short course of immunotherapy prior to surgery effective in treating a subset of colon cancer patients

Preoperative antibiotic treatment does not reduce infection risk after pediatric elbow fracture surgery

New bilateral gene therapy shows promising results in treating genetic hearing loss

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

5-Cog paradigm: A breakthrough in dementia diagnosis and care

New program aims to reduce the strain on caregivers of children with ADHD

Novel combination treatment outperforms standard therapy in patients with EGFR NSCLC

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News